Anti-atherosclerotic Efficacy of Selected Antidiabetic Drugs in Patients With Coronary Artery Disease and Pre-diabetes
A phase 4 trial registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 300 participants.
Also called NCT07254572
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose treatment
- Phase
- Phase 4
- Enrolled
- 300 participants
- Registry
-
NCT07254572
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- Poland
- Registry status
- Recruiting
Technical summary
Registry record NCT07254572. Randomized; no masking; primary purpose treatment. Start 2025-07-10 (actual); primary completion 2029-08-01 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Anti-atherosclerotic Efficacy of Selected Antidiabetic Drugs in Patients With Coronary Artery Disease and Pre-diabetes
- Acronym
- CASCADES
- Condition
- Coronary Artery Disease
- Condition
- PreDiabetes
- Intervention (Drug)
- Semaglutide 14 MG [Rybelsus]
- Intervention (Drug)
- Dapagliflozin (Forxiga)
- Intervention (Drug)
- Metformin
- Intervention (Behavioral)
- Optimal Medical Therapy (OMT) And Lifestyle Intervention
- Lead sponsor
- National Institute of Cardiology, Warsaw, Poland
- Collaborator
- Medical Research Agency, Poland
Record details
- Record id
cardio:ct-nct07254572- Content hash
e905a60716608b8369a8a3b5883bc6c6e920eb5f129958ee279150ac543cda30